Published in Cancer Vaccine Week, September 5th, 2005
In the second quarter of 2005, Point reported a net loss of $5,143,000 or $0.23 per share, compared with a net loss of $3,008,000, or $0.17 per share, in the second quarter of 2004. For the first 6 months of 2005, Point reported a net loss of $10,059,000 or $0.48 per share compared with a net loss of $6,143,000 or $0.37 per share for the first 6 months of 2004.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week